Jacek Olczak, Philip Morris International CEO, joins CNBC's 'Money Movers' to discuss the company's most recent earnings.

Adjusted additionally for expected currency impact, Philip Morris expects 2025 earnings of $7.26 a share to $7.39 a share.

The U.S. Food and Drug Administration (FDA), the US governmental authority responsible for regulating foods and medical ...

Philip Morris International exceeded earnings expectations for Q4, propelled by its expanding smoke-free product lineup.

Jacek Olczak; Chief Executive Officer, Director; Philip Morris International Inc Emmanuel Babeau; Chief Financial Officer; Philip Morris International Inc Matthew Smith; Analyst; Stifel, Nicolaus & Co ...

Philip Morris' impressive Q3 results highlight robust performance in both core and reduced-risk products. Read why I remain ...

Philip Morris International Inc. (NYSE:PM) shares are trading higher on Thursday after fourth-quarter FY24 earnings result.

Zyn is manufactured by Swedish Match, which Philip Morris International acquired in a $16 billion deal in 2022. That year, ...

ZYN, the popular brand of flavored nicotine pouches, recently earned FDA authorization for reducing smoking, but some ...

Organic net revenue growth for 2025 is targeted at 6-8%, supported by strong growth in smoke-free categories and resilient combustibles. Adjusted diluted EPS is expected to range between $7.04 and ...

Philip Morris International Inc. (PMI) (NYSE: PM) today announces its 2024 fourth-quarter and full-year results.1 "2024 was a remarkable year ...

The FDA determined that "due to substantially ... Zyn is manufactured by Swedish Match, which Philip Morris International acquired in a $16 billion deal in 2022. That year, Zyn shipped 238 ...